Mycotic wound infections. A new challenge of the surgeon.

Fungal wound infections have become more common because of the increased use of immunosuppressive and antineoplastic agents, prosthetic devices and grafts, broad-spectrum antibiotics, and hyperalimentation. Severe burns, renal failure, and other debilitating conditions also predispose to invasive mycoses. An aggressive diagnostic approach is particularly important, and tissue biopsy specimens are often necessary to establish a diagnosis. Meticulous surgical technique and minimization of the predisposing factors are crucial in the prevention of these infections, and prophylactic antimycotic agents may be of value in selected high-risk patients. Some mycotic wound infections can be managed effectively without systemic therapy; but when systemic agents are needed, combination antifungal therapy may provide improved results without increased drug toxicity.

[1]  R. N. Brogden,et al.  Miconazole: A Review of its Antifungal Activity and Therapeutic Efficacy , 2012, Drugs.

[2]  E. Berman Excision of pulmonary and renal aspergillomas : R. J. Ippolito, J. H. Seashore, and R. J. Touloukian. Arch Surg 113:640–642, (May), 1978 , 1979 .

[3]  P. Gross,et al.  Disseminated Cryptococcus treated with transfer factor. , 1978, Journal of the American Medical Association (JAMA).

[4]  G. Keusch,et al.  Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. , 1978, The New England journal of medicine.

[5]  J. S. Clarke,et al.  Veterans Administration Cooperative Study on Bowel Preparation for Elective Colorectal Operations: Impact of Oral Antibiotic Regimen on Colonic Flora, Wound Irrigation Cultures and Bacteriology of Septic Complications , 1978, Annals of surgery.

[6]  D. Maki,et al.  Mucormycosis. A complication of critical care. , 1978 .

[7]  D. Maki,et al.  Management of septic thrombosis of the inferior vena cava caused by Candida. , 1978, Archives of surgery.

[8]  R. Touloukian,et al.  Excision of pulmonary and renal aspergillomas. Its use in treating chronic granulomatous disease of childhood. , 1978, Archives of surgery.

[9]  C. Bryan,et al.  Cryptococcal meningitis. Fatal marrow aplasia from combined therapy. , 1978, JAMA.

[10]  O'Leary Jp,et al.  Effect of preparation of the small intestine on microflora and postoperative wound infection. , 1978 .

[11]  J. John Nosocomial infection rates at a General Army Hospital. , 1977, American journal of surgery.

[12]  M. Levin,et al.  Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B. , 1977, The Journal of infectious diseases.

[13]  R. Diamond Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis , 1977, Infection and immunity.

[14]  R. Ehrlich,et al.  Systemic candidiasis following cardiac surgery: an improved outlook. , 1977, Southern medical journal.

[15]  K. Alestig,et al.  Combined treatment with amphotericin B and flucytosine in severe fungal infections. , 1976, The Journal of antimicrobial chemotherapy.

[16]  J. Tobias,et al.  Managing systemic mycoses in the compromised host. , 1976, JAMA.

[17]  Louria Db Candida and aspergillus infections. , 1976 .

[18]  T. Starzl,et al.  Cryptococcosis after renal transplantation: report of ten cases. , 1976, Surgery.

[19]  A. Monaco,et al.  Immunosuppressive Therapy Following Cryptococcal Meningitis , 1976 .

[20]  P. J. Grob,et al.  SOME PHYSICO-CHEMICAL AND BIOLOGICAL PROPERTIES OF A TRANSFER FACTOR PREPARATION AND ITS CLINICAL APPLICATION , 1976 .

[21]  C. Vallejos,et al.  White Blood Cell Transfusions for Control of Infections in Neutropenic Patients , 2003, Transfusion.

[22]  G. Bodey,et al.  Successful control of systemic aspergillus niger infections in two patients with acute leukemia , 1975 .

[23]  H. Balfour,et al.  Infection in immunosuppressed transplant recipients. , 1975, The Surgical clinics of North America.

[24]  B. Varkey,et al.  DEEP MYCOTIC INFECTION IN THE HOSPITALIZED ADULT: A STUDY OF 123 PATIENTS , 1975, Medicine.

[25]  J B Grogan,et al.  Efficacy of inline bacterial filters in reducing contamination of intravenous nutritional solutions. , 1975, American journal of surgery.

[26]  M. Sande,et al.  Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. , 1975, The Journal of infectious diseases.

[27]  G. Bodey,et al.  Infections in cancer patients on a protected environment-prophylactic antibiotic program. , 1975, The American journal of medicine.

[28]  J. Rahal,et al.  FUNGAL ENDOCARDITIS: ANALYSIS OF 24 CASES AND REVIEW OF THE LITERATURE , 1975, Medicine.

[29]  E. Harder,et al.  Treatment of fungal infections with flucytosine. , 1975, Archives of internal medicine.

[30]  M. Levison,et al.  Cure of Aspergillus ustus endocarditis on a prosthetic valve. , 1974, Archives of internal medicine.

[31]  H. Stone Studies in the pathogenesis, diagnosis, and treatment of Candida sepsis in children. , 1974, Journal of pediatric surgery.

[32]  J. Bennett Chemotherapy of systemic mycoses (first of two parts). , 1974, The New England journal of medicine.

[33]  Bennett Je Diagnosis and therapy of systemic mycoses in the immunosuppressed host. , 1973 .

[34]  H. Stone,et al.  Alimentary tract colonization by Candida albicans. , 1973, The Journal of surgical research.

[35]  A. Monaco,et al.  Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. , 1973, Lancet.

[36]  L. Young,et al.  Aspergillosis complicating neoplastic disease. , 1973, The American journal of medicine.

[37]  G. Medoff,et al.  Synergistic Action of Amphotericin B and 5-Fluorocytosine Against Yeast-Like Organisms 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.